Bioequivalence Study of Perampanel Tablets 12 mg

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 14, 2023

Primary Completion Date

September 20, 2023

Study Completion Date

December 5, 2023

Conditions

Epilepsy

Interventions

DRUG

Perampanel 12 MG

1 tablet of Perampanel Tablets 12 mg

DRUG

Fycompa 12 mg film-coated tablets

1 tablet of Perampanel Tablets 12 mg

Trial Locations (1)

Raptim Research Pvt. Ltd.,, Navi Mumbai

All Listed Sponsors

lead

Humanis Saglık Anonim Sirketi

INDUSTRY

NCT06450223 - Bioequivalence Study of Perampanel Tablets 12 mg | Biotech Hunter | Biotech Hunter